Rivista di formazione e aggiornamento di pediatri e medici operanti sul territorio e in ospedale. Fondata nel 1982, in collaborazione con l'Associazione Culturale Pediatri
Gli articoli più visti nel mese di Luglio 2026
1) Editoriali - Aprile 2024
2) Linee guida - Giugno 2026
Management della febbre nei primi 60 giorni di vita: fare meno, ma in sicurezza
- Cardace MG, Fiandri G, Baroni L, et al.
- Fever in neonates and infants younger than 60 days is one of the most frequent cause of admission to the Paediatric Emergency Room and a significant clinical challenge. Although the majority of infections in this age group are viral, a non-negligible risk of invasive bacterial infections (IBIs), including bacteremia and bacterial meningitis, persists. The clinical presentation is often nonspecific and physical examination alone has low sensitivity for identifying serious bacterial disease. This paper provides a summary of the most recent evidence on the management of febrile newborns and infants (<60 days), with particular reference to the guidelines of the American Academy of Pediatrics, and compares them with European and British approaches. AAP recommendations propose an age-stratified decision-making model (8-21, 22-28, and 29-60 days) integrating clinical assessment with inflammatory biomarkers, particularly procalcitonin, C-reactive protein and absolute neutrophil count. This strategy allows clinicians to tailor the indication for invasive testing, hospitalisation and empiric antibiotic therapy according to the neonate/infant’s risk profile, thereby reducing unnecessary interventions in low-risk infants without compromising patient safety. Available evidence shows that the combined use of inflammatory biomarkers, especially procalcitonin, has a high negative predictive value for IBIs and supports a more selective approach to lumbar puncture and hospitalisation. In conclusion, the management of febrile neonates and infants younger than 60 days should be based on a structured and cautious approach able to balance the need for early identification of serious bacterial infections with the goal of limiting unnecessary diagnostic and therapeutic interventions.
6) Casi indimenticabili - Giugno 2026
Un’artralgia che co... vava qualcosa
- Stella A, Iacono A, Magno C, Fichera F, Schilleci A, Cassata N.
- The paper describes the case of a 4-year-old girl with Jacobsen syndrome and a history of highly selective eating, who presented with anaemia, arthralgia and a sudden refusal to bear weight following a minor knee injury. The condition, which proved to be a case of scurvy, highlights the clinical significance of severe nutritional deficiencies in paediatric patients with selective diets or developmental disorders.
6) Casi indimenticabili - Giugno 2026
Una tosse “ticcosa”
- Colonna F, Marsoni B.
- The paper describes the case of a 6-year-old girl with diurnal, drug-resistant tic (psychogenic) cough triggered by a traumatic hospitalisation. Once organic causes were ruled out, the issue was permanently resolved through psychotherapy combined with EMDR.
6) Casi indimenticabili - Giugno 2026
Dolore toracico e pericardite
- Fasiolo E.
- The paper describes the case of a 14-year-old boy who presented to the Emergency Room with positional chest pain and ECG changes. Based on his symptoms and rising CRP levels, he was discharged with a diagnosis of acute pericarditis and prescribed ibuprofen, colchicina and rest. At the follow-up visit two days later, the pain had reduced, but typical pericardial friction rubs were detected.
8) Editoriali - Giugno 2026
9) Aggiornamento - Aprile 2008
L'ipertensione arteriosa in età pediatrica: dall'inquadramento diagnostico alla terapia
- A. de Cunto, M. Maschio, M. Pennesi, A. Benettoni
- The epidemic of childhood obesity, the risk of developing left ventricular hypertrophy, and evidence of the early development of atherosclerosis in children would make identification and treatment of hypertension an important focus of physicians caring for children. Secondary hypertension is more common in preadolescent children, with most cases caused by renal disease. Primary or essential hypertension is an emerging condition in adolescents and has multiple risk factors, including obesity and a family history of hypertension. Evaluation involves a thorough history and physical examination, laboratory tests, and specialized studies. Lifestyle modifications are advised for all patients and can be tried solely for those with blood pressures between the 95th and 99th percentiles. Drug therapy is indicated in children with blood pressures greater than the 99th percentile, secondary hypertension, coexisting diabetes, left ventricular hypertrophy, or those who fail a trial of non pharmacologic treatment.
10) Linee guida - Ottobre 2020
La prima infezione urinaria febbrile in bambini di età compresa tra 2 mesi e 3 anni
- Gruppo di lavoro sulle infezioni delle vie urinarie della Società Italiana di Nefrologia Pediatrica (SINePe)
- The aim was to update the recommendations for the diagnosis, treatment and follow-up of the first febrile urinary tract infection in young children, which were first published in 2012 and endorsed by the Italian Society of Paediatric Nephrology. The Italian recommendations were revised on the basis of a review of the literature published from 2012 to October 2018. An ad hoc evaluation of the risk factors, which were published in the previous recommendations, was carried out to identify children with high-grade vesicoureteral reflux or renal scarring. When evidence was not available, the working group held extensive discussions during various meetings and through email exchanges. Four major modifications have been introduced. The method for collecting urine for culture and its interpretation has been re-evaluated. The algorithm that guides clinical decisions to proceed with voiding cystourethrography has been reformulated. The suggested antibiotics have been revised and further restrictions of the use of antibiotic prophylaxis have been recommended. These updated recommendations have now been endorsed by the Italian Society of Paediatric Nephrology and the Italian Society for Paediatric Infectivology. They can also be used to compare other available recommendations, as a worldwide consensus in this area is still lacking.

44 kB